Pure Global

Roche human epithelial factor receptor 2 protein rabbit monoclonal antibody - Taiwan Registration b76dc0d4d46854b1f371cc37dc22c542

Access comprehensive regulatory information for Roche human epithelial factor receptor 2 protein rabbit monoclonal antibody in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number b76dc0d4d46854b1f371cc37dc22c542 and manufactured by ROCHE DIAGNOSTICS GMBH;; VENTANA MEDICAL SYSTEMS, INC.. The authorized representative in Taiwan is ROCHE DIAGNOSTICS LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
b76dc0d4d46854b1f371cc37dc22c542
Registration Details
Taiwan FDA Registration: b76dc0d4d46854b1f371cc37dc22c542
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Roche human epithelial factor receptor 2 protein rabbit monoclonal antibody
TW: ็พ…ๆฐไบบ้กžไธŠ็šฎๅ› ๅญๆŽฅๅ—้ซ”็ฌฌ2่›‹็™ฝๅ…”ๅญๅ–ฎๆ ชๆŠ—้ซ”
Risk Class 3

Registration Details

b76dc0d4d46854b1f371cc37dc22c542

DHA05602754200

Company Information

Product Details

This product is used to semi-quantitatively detect HER2 antigen in formalin-fixed, paraffin-embedded normal and breast cancer tumor tissues on the Ventana autoimmune histochemical section stainer. This product can be used as an adjunct to assess the suitability of breast cancer patients for Herceptin, and can be used as an aid to assess the suitability of breast cancer patients for Kadcyla (trastuzumab emtansine) or Perjeta (pertuzumab).

B Hematology, pathology, and genetics

B.1860 Immunopathological histochemistry reagents and kits

Contract manufacturing;; input

Dates and Status

Aug 04, 2015

Aug 04, 2025